Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Neuroscience technology company Brooklyn Health is using artificial intelligence to target a fundamental problem in neurology ...

Results for IRAKLIA show noninferiority for Sanofi's on-body delivery system for isatuximab, compared with IV administration.

Results from a new study help resolve the decade-long mystery of why many patients with the deadliest form of skin cancer do ...

Brian Peters started his new role as SVP of the AI Squared division at Apimeds Pharmaceuticals. Pharma market research firm Konovo named Tim Albury as CFO. Tenpoint Therapeutics announced the ...

The Seattle-based company came to ASCO25 with new data on its neuroendocrine tumor–treating lead therapy, with big vibes and ...

Lisocabtagene maraleucel significantly improved responses rates and survival outcomes among patients with relapsed or refractory chronic lymphocytic leukemia, according to findings presented at ASCO ...

Trastuzumab deruxtecan plus pertuzumab outperformed standard-of-care therapy as first-line treatment for HER2-positive ...

Bristol-Myers Squibb and BioNTech announced a major deal worth up to $11 billion in early June. Click here to find out why I ...

The Florida State University community mourns the loss of esteemed chemist and noted inventor Robert Holton, whose ...

A leading Chinese expert has noted the importance of implementing innovative digital assessment and monitoring systems to ...

Tests in 1,225 patients with the most deadly form of skin cancer reveal for the first time a genetic trait among most of those who did not respond to the latest cancer treatments, known as immune ...